UCB is heading into 2024 with several new approvals under its belt, but it’s leaving its membership in the Biotechnology Innovation Organization (BIO) behind.
The company opted not to renew its membership in the industry trade group after a routine evaluation of association memberships, a spokesperson confirmed over email.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,